Tissue Regenix Group PLC

Receive alerts
Market Cap:
£37.74 m
52 weeks high
52 weeks low

Viewing results 1-25 of 149


Tissue Regenix's production capacity increases should bear fruit in the second half

During the first half, the regenerative medicines specialist streamlined its logistics network and enhanced its operational procedures...

1 week ago

Tissue Regenix appoints interim finance chief Barker to full-time role

The regenerative medical devices specialist said Mike Barker will join the board with immediate effect having held the role on an interim basis since the start of the year...

2 weeks, 6 days ago

Tissue Regenix adds manufacturing capacity in US expansion push

“Having commenced a second shift at the beginning of the year in our current facility in San Antonio, the phased build out of this new facility will allow us to meet the growing requirements of our customers well into the future," said boss Gareth Jones...

on 08/15/2019

Tissue Regenix chief executive steps down as illness recurs

John Samuel will resume as executive chairman until a full-time chief executive is appointed...

on 08/01/2019

Fund manager Randeep Grewal appointed new chairman of BB Healthcare

Justin Stebbing is stepping down after three years in the role, and Randeep Grewal has been appointed as his successor with immediate effect...

on 07/17/2019

Tissue Regenix secures US$20mln credit facility; says current trading is in line

“The additional capital secured through the credit facilities allows us to focus on further scaling the manufacturing capacity of the business and pursue further partnership opportunities, driving the business trajectory towards self-sustainability,” said chief executive Steve Couldwell. ...

on 06/04/2019

Tissue Regenix boss to return to full-time duties in June

Steve Couldwell has been out of action so far this year while he undergoes medical treatment...

on 05/21/2019

Tissue Regenix secures additional coverage for DermaPure from a US Group Purchasing Organization

The AIM-listed firm said the additional coverage will open up access to a further 1,500 hospitals and 32,500 alternative care providers, primarily in the South Eastern region of the US...

on 04/04/2019

Tissue Regenix continues regeneration as it targets breaking even by 2020

Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier...

on 02/20/2019

Tissue Regenix flush with cash after doubling revenues in 2018

Bosses expect to move another step closer towards profitability in the year ahead, before breaking even in 2020 – a long-term target for the group...

on 02/04/2019

Tissue Regenix boss to take leave of absence to undergo medical treatment

Steve Couldwell will step aside in January in order to undergo treatment for an unspecified medical condition, although he should be back by March...

on 12/06/2018

Tissue Regenix shares rise as CellRight expands on Arthrex Inc relationship with European distribution deal

The AIM-listed firm said the agreement would allow Arthrex to distribute CellRight’s proprietary ‘BioRinse’ portfolio across Europe, with an initial focus on the UK...

on 11/13/2018

New Tissue Regenix CFO to step into role earlier than anticipated

Gareth Jones was supposed to take up his new role at the end of November, but having already completed the handover at his old company, he starts today (Monday)...

on 10/29/2018

Tissue Regenix makes strong operational and financial progress

Chief executive Steve Couldwell also told investors the regenerative medicines specialist had identified a number of potential new commercial opportunities it was “actively pursuing”...

on 09/03/2018

Tissue Regenix appoints new chief financial officer

The AIM-listed firm said Jones will join the group as CFO, company secretary and as an executive director on board on 30 November 2018...

on 07/04/2018

Tissue Regenix granted HTA licence, signs UK distribution deal

The Human Tissue Authority licence will allow Tissue to import and distribute products made by CellRight, the US business it agreed to buy last summer...

on 06/25/2018

Tissue Regenix wins award at US conference

The medical devices maker won the Supplier Horizon award at a conference hosted by group purchasing organisation Premier...

on 06/21/2018

Tissue Regenix Group inks new US deal, providing access to 3,900 hospitals

The company's flagship product DermaPure is gaining traction in the States...

on 05/02/2018

Tissue Regenix's US manufacturing transfer completed ahead of schedule

The switch to the CellRight facility in Texas confers a number of benefits ...

on 04/24/2018

Tissue Regenix ready to kick on after year of change

"We are now in the position of really trying to kick on in 2018"...

on 03/31/2018

Tissue Regenix says sales in CellRight and BioSurgery divisions started year strongly

"We have completed a transformative acquisition, delivered 46% growth in DermaPure sales and expanded the clinical applications of our products to access new healthcare professionals," said company chairman, John Samuel...

on 03/26/2018